LEN vs PRVA · rev $34.19B vs P/E 135, $2.90B cap
LEN (LEN) versus Privia Health Group Inc (PRVA) — a side-by-side from cached financials, not a winner call.
LEN (LEN) common stock.
Privia Health Group Inc (PRVA) is a health information services company listed on NASDAQ.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
PRVA does not have a complete income-statement cache yet.
LEN currently screens at market cap $0. PRVA currently screens at market cap $2.90B and trailing P/E 135.4.
Not investment advice. Open the LEN and PRVA stock pages for the full models.
Not investment advice.